Net profit of Caplin Point Laboratories rose 23.26% to Rs 152.80 crore in the quarter ended June 2025 as against Rs 123.97 crore during the previous quarter ended June 2024. Sales rose 11.17% to Rs 510.22 crore in the quarter ended June 2025 as against Rs 458.96 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 510.22 | 458.96 | 11 |
OPM % | 34.84 | 33.08 | - |
PBDT | 200.75 | 170.34 | 18 |
PBT | 184.46 | 154.38 | 19 |
NP | 152.80 | 123.97 | 23 |